Method and composition for modulating immune response
Provided is a method for modulating an immune response which is not derived from alphavirus infection comprising administering to a subject in need thereof an effective amount of a composition comprising an alphavirus virus like particle.
1. A method for modulating an immune response against a cancer, wherein said method comprises administering, to a subject with a cancer, an effective amount of a composition comprising an alphavirus virus like particle, wherein said alphavirus virus like particle does not contain a heterologous antigen.
2. The method of claim 1 , wherein said modulating is the enhancement of an immune response against said cancer.
3. The method of claim 1 , wherein the virus like particle comprises a viral structural protein of Chikungunya strain OPY-1, Chikungunya strain 37997 or Venezuelan equine encephalitis virus TC-83 strain.
4. The method of claim 1 , wherein the alphavirus is Chikungunya virus.
5. The method of claim 2 , wherein the alphavirus is Chikungunya virus.
6. The method of claim 3 , wherein the alphavirus is Chikungunya virus.
7. The method of claim 3 , wherein the viral structural protein is a viral structural protein of Chikungunya strain OPY-1 or Chikungunya strain 37997.